# The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus

Study · id `cardio:ct-nct06648174` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06648174](<https://clinicaltrials.gov/study/NCT06648174>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06648174

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

## Technical summary

Registry record NCT06648174. Randomized; no masking; primary purpose supportive care. Start 2024-11-11 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT06648174, source copy `cardio:ctgov-nct06648174-2026-01-20`, retrieved 2026-10-26)
- Started: 2024-11-11 (actual) (ClinicalTrials.gov record NCT06648174, source copy `cardio:ctgov-nct06648174-2026-01-20`, retrieved 2026-10-26)
- Primary completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT06648174, source copy `cardio:ctgov-nct06648174-2026-01-20`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT06648174, source copy `cardio:ctgov-nct06648174-2026-01-20`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT06648174, source copy `cardio:ctgov-nct06648174-2026-01-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06648174-2026-01-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Project for Managing Cardiometabolic Risk in Women Diagnosed With Gestational Diabetes Mellitus
- Condition: Gestational Diabetes Mellitus
- Condition: Continuous Glucose Monitoring
- Intervention (Device): Continuous glucose monitor
- Intervention (Behavioral): Perinatal nursing care for gestational diabetes
- Intervention (Other): Blood glucose meters (BGM)
- Lead sponsor: National Taiwan University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: National Taiwan University Hospital (`cardio:org-national-taiwan-university-hospital`)

## Provenance

Content hash: ace17794ed7bfed5c77cd179e66136e05c4e9f3001ad784afbcbd911f0678d6e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
